Tocolytic therapy in conservative management of symptomatic placenta previa

References 

1. Iyasu S, Saftlas AK, Rowley DL, Koonin LM, Lawson HW, Atrash HK. The epidemiology of placenta previa in the United States, 1979 through 1987. Am J Obstet Gynecol. 1993;168:1424–1429
   • Abstract
   • Full-Text PDF (591 KB)
2. Harrison K, Rossiter CE. Maternal mortality. Br J Obstet Gynecol. 1985;5(Suppl):100–115
3. McShane PM, Heyl PS, Epstein MF. Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol. 1985;65:176–182
   • MEDLINE
4. Silver R, Depp R, Sabbagha RE, Dooley SL, Socol ML, Tamura RK. Placenta previa: aggressive expectant management. Am J Obstet Gynecol. 1984;150:15–22
   • MEDLINE
5. Tomich PG. Prolonged use of tocolytic agents in the expectant management of placenta previa. J Reprod Med. 1985;30:745–748
   • MEDLINE
6. Magann EF, Johnson CA, Gookin KS, Roberts WE, Martin RW, Morrison JC. Placenta previa. Does uterine activity cause bleeding. Aus N Z J Obstet Gynecol. 1993;33:22–24
7. Martin JN, McColgin SW, Martin RW, Roach H, Morrison JC. Uterine activity among a diverse group at risk for preterm delivery. Obstet Gynecol. 1990;76:47S–51S
   • MEDLINE
8. Newman RB, Campbell BA, Stramm SL. Objective tocodynamometry identifies labor onset earlier than subjective maternal perception. Obstet Gynecol. 1990;76:1089–1092
   • MEDLINE
9. Besinger RE, Moniak CW, Paskiewicz LS, Fisher SG, Tomich PG. The effect of tocolytic use in the management of symptomatic placenta previa. Am J Obstet Gynecol. 1995;172:1770–1778
   • Abstract
   • Full-Text PDF (890 KB)
   • CrossRef
10. Towers CV, Pircon RA, Heppard M. Is tocolysis safe in the management of third trimester bleeding?. Am J Obstet Gynecol. 1999;180:1572–1578
    • Abstract
    • Full Text
    • Full-Text PDF (103 KB)
    • CrossRef
11. Moutquin JM, Effer SB, Milner RA, et al.  Treatment of preterm labour with beta-adrenergic agonist ritodrine. N Engl J Med. 1992;327:308–312
    • MEDLINE
    • CrossRef